Alan Prem Kumar
Principal Associate
Oncology
Cancer science institute of singapore
Singapore
Biography
Dr Alan Prem Kumar’s group focuses on the study of metastatic disease, specifically in breast cancer. Over 90 percent of the morbidity and mortality that results from cancer is due to metastasis. Thus, the understanding of this process is crucial to the development of novel therapies for cancer patients. Discoveries in these areas lead to the identification of a novel oncogene that regulates key pathways controlling cell proliferation, migration and drug resistance in breast, prostate, gastric, and colon cancers. His second research area is to understand the roles of nuclear receptors and epigenetics in regulating gene expression in breast cancer so that we can develop more effective and safer drug treatment for patients. Development of molecular therapeutics and biomarkers of drug action in breast cancer is also of great interest within his group.
Research Interest
Oncology
